Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alexandra M. Wiley, Jade Yang, Rivcka Madhani, Abhinav Nath & Rheem A. Totah. (2024) Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review. Drug Metabolism Reviews 0:0, pages 1-19.
Read now
Read now
Michael Murray. (2016) CYP2J2 – regulation, function and polymorphism. Drug Metabolism Reviews 48:3, pages 351-368.
Read now
Read now
Meijuan Xu, Wenzheng Ju, Haiping Hao, Guangji Wang & Ping Li. (2013) Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance. Drug Metabolism Reviews 45:3, pages 311-352.
Read now
Read now
Wei Zhang, Mary W Roederer, Wang-Qing Chen, Lan Fan & Hong-Hao Zhou. (2012) Pharmacogenetics of Drugs Withdrawn from the Market. Pharmacogenomics 13:2, pages 223-231.
Read now
Read now
A. Messina, S. Nencioni, P. G. Gervasi, K. H. Gotlinger, M. L. Schwartzman & V. Longo. (2010) Molecular cloning and enzymatic characterization of sheep CYP2J. Xenobiotica 40:2, pages 109-118.
Read now
Read now
Hongjian Zhang, Carl D Davis, Michael W Sinz & A David Rodrigues. (2007) Cytochrome P450 reaction-phenotyping: an industrial perspective. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 667-687.
Read now
Read now
H. Yamazaki, A. Okayama, N. Imai, F. P. Guengerich & M. Shimizu. (2006) Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations. Xenobiotica 36:12, pages 1201-1209.
Read now
Read now
Articles from other publishers (24)
Jacqueline Wen Hui Leow & Eric Chun Yong Chan. (2024) CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control. Pharmacology & Therapeutics 258, pages 108637.
Crossref
Crossref
Hani Zaher & George Zhang. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
737
756
.
Albert P. Li. 2021. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity
79
137
.
Helinä Kahma, Laura Aurinsalo, Mikko Neuvonen, Jani Katajamäki, Marie-Noëlle Paludetto, Jenni Viinamäki, Terhi Launiainen, Anne M. Filppula, Aleksi Tornio, Mikko Niemi & Janne T. Backman. (2021) An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes – application to establishing CYP2C8 inhibitor selectivity. European Journal of Pharmaceutical Sciences 162, pages 105810.
Crossref
Crossref
Jian Lu, Ang Chen, Xinrun Ma, Xuyang Shang, Yuanjin Zhang, Yuanqing Guo, Mingyao Liu & Xin Wang. (2020) Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model. Drug Metabolism and Disposition 48:11, pages 1129-1136.
Crossref
Crossref
Marco Sisignano, Dieter Steinhilber, Michael J. Parnham & Gerd Geisslinger. (2020) Exploring CYP2J2: lipid mediators, inhibitors and therapeutic implications. Drug Discovery Today 25:9, pages 1744-1753.
Crossref
Crossref
Hyun‐Ji Kim, Hyunyoung Lee, Hyeon‐Kyeong Ji, Taeho Lee & Kwang‐Hyeon Liu. (2019) Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography–tandem mass spectrometry. Biopharmaceutics & Drug Disposition 40:3-4, pages 101-111.
Crossref
Crossref
Pierre Lafite, François André, Joan Graves, Darryl Zeldin, Patrick Dansette & Daniel Mansuy. (2018) Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2. International Journal of Molecular Sciences 19:7, pages 2066.
Crossref
Crossref
Jian Lu, Daozhi Liu, Xiaojing Zhou, Ang Chen, Zhenran Jiang, Xiyun Ye, Mingyao Liu & Xin Wang. (2018) Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme. Phytomedicine 39, pages 137-145.
Crossref
Crossref
Dany Spaggiari, Youssef Daali & Serge Rudaz. (2016) An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure. Toxicology and Applied Pharmacology 302, pages 41-51.
Crossref
Crossref
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450
523
785
.
José A. G. Agúndez, Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro & Elena GarcÃa-MartÃn. (2014) Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref
Boram Lee, Zhexue Wu, Sang Hyun Sung, Taeho Lee, Kyung-Sik Song, Min Young Lee & Kwang-Hyeon Liu. (2014) Potential of decursin to inhibit the human cytochrome P450 2J2 isoform. Food and Chemical Toxicology 70, pages 94-99.
Crossref
Crossref
Boram Lee, Wonku Kang, Jongcheol Shon, Ki Hun Park, Kyung-Sik Song & Kwang-Hyeon Liu. (2014) Potential of 4′-(p-toluenesulfonylamide)-4-hydroxychalcone to inhibit the human cytochrome P450 2J2 isoform. Journal of the Korean Society for Applied Biological Chemistry 57:1, pages 31-34.
Crossref
Crossref
Zhexue Wu, Boram Lee, Kyung-Sik Song & Kwang-Hyeon Liu. (2013) Inhibitory Potential of Thelephoric Acid on CYP2J2 Activities in Human Liver Microsomes. Journal of Life Science 23:9, pages 1126-1132.
Crossref
Crossref
Caroline A. Lee, J. P. JonesIIIIII, Jonathan Katayama, Rüdiger Kaspera, Ying Jiang, Sascha Freiwald, Evan Smith, Gregory S. Walker & Rheem A. Totah. (2012) Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity. Drug Metabolism and Disposition 40:5, pages 943-951.
Crossref
Crossref
Kwang-Hyeon Liu. (2011) Screening of Potential Anticancer Compounds from Marketed Drugs: Aripiprazole, Haloperidol, Miconazole, and Terfenadine Inhibit Cytochrome P450 2J2. Journal of Life Science 21:11, pages 1558-1564.
Crossref
Crossref
Anima Ghosal, Xiaowen Lu, Natalia Penner, Lan Gao, Ragu Ramanathan, Swapan K. Chowdhury, Narendra S. Kishnani & Kevin B. Alton. (2011) Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist. Drug Metabolism and Disposition 39:1, pages 30-38.
Crossref
Crossref
Caroline A. Lee, David Neul, Andrea Clouser-Roche, Deepak Dalvie, Michael R. Wester, Ying Jiang, J. P. JonesIIIIII, Sascha Freiwald, Michael Zientek & Rheem A. Totah. (2010) Identification of Novel Substrates for Human Cytochrome P450 2J2. Drug Metabolism and Disposition 38:2, pages 347-356.
Crossref
Crossref
Kirstin Thelen & Jennifer B Dressman. (2009) Cytochrome P450-mediated metabolism in the human gut wall. Journal of Pharmacy and Pharmacology 61:5, pages 541-558.
Crossref
Crossref
Weihua Li, Yun Tang, Hong Liu, Jiagao Cheng, Weiliang Zhu & Hualiang Jiang. (2007) Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Proteins: Structure, Function, and Bioinformatics 71:2, pages 938-949.
Crossref
Crossref
Kwang-Hyeon Liu, Mi-Gyung Kim, Dong-Jun Lee, Yune-Jung Yoon, Min-Jung Kim, Ji-Hong Shon, Chang Soo Choi, Young Kil Choi, Zeuresenay Desta & Jae-Gook Shin. (2006) Characterization of Ebastine, Hydroxyebastine, and Carebastine Metabolism by Human Liver Microsomes and Expressed Cytochrome P450 Enzymes: Major Roles for CYP2J2 and CYP3A. Drug Metabolism and Disposition 34:11, pages 1793-1797.
Crossref
Crossref
Pierre Lafite, Sylvie Dijols, Didier Buisson, Anne-Christine Macherey, Darryl C. Zeldin, Patrick M. Dansette & Daniel Mansuy. (2006) Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2. Bioorganic & Medicinal Chemistry Letters 16:10, pages 2777-2780.
Crossref
Crossref
Sang Seop Lee, Hye-Eun Jeong, Kwang-Hyeon Liu, Ji-Young Ryu, Taesung Moon, Chang No Yoon, S. June Oh, Chul-Ho Yun & Jae-Gook Shin. (2005) Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity. Pharmacogenetics and Genomics 15:2, pages 105-113.
Crossref
Crossref